Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 4 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Choline PET/CT in recurrent prostate cancer.
Front Oncol. 2023 Mar 21;13:1079808. doi: 10.3389/fonc.2023.1079808. eCollection 2023.
Front Oncol. 2023.
PMID: 37025599
Free PMC article.
Pattern of recurrence after stereotactic body radiotherapy for para-aortic oligo-recurrent prostate cancer, a multicentric analysis.
Francolini G, Garlatti P, Di Cataldo V, Triggiani L, Simoni N, Detti B, Lorenzetti V, Colombo F, Morelli V, Ganovelli M, Caprara L, Orsatti C, Burchini L, Frosini G, Bertini N, Loi M, Simontacchi G, Greto D, Desideri I, Meattini I, Livi L.
Francolini G, et al. Among authors: burchini l.
Radiol Med. 2023 Nov;128(11):1423-1428. doi: 10.1007/s11547-023-01701-x. Epub 2023 Aug 19.
Radiol Med. 2023.
PMID: 37597125
Item in Clipboard
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275).
Francolini G, Loi M, Ciccone LP, Detti B, Di Cataldo V, Pinzani P, Salvianti F, Salvatore G, Sottili M, Santini C, Frosini G, Visani L, Burchini L, Mattioli C, Allegra AG, Valzano M, Cerbai C, Aquilano M, Salvestrini V, Desideri I, Mangoni M, Meattini I, Livi L.
Francolini G, et al. Among authors: burchini l.
Med Oncol. 2022 Jun 10;39(8):119. doi: 10.1007/s12032-022-01756-2.
Med Oncol. 2022.
PMID: 35687207
Item in Clipboard
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736).
Francolini G, Garlatti P, Di Cataldo V, Detti B, Loi M, Greto D, Simontacchi G, Morelli I, Burchini L, Allegra AG, Frosini G, Ganovelli M, Salvestrini V, Olmetto E, Visani L, Becherini C, Valzano M, Carnevale MG, Roghi M, Serni S, Mattioli C, Desideri I, Livi L.
Francolini G, et al. Among authors: burchini l.
Cancers (Basel). 2023 Feb 3;15(3):992. doi: 10.3390/cancers15030992.
Cancers (Basel). 2023.
PMID: 36765948
Free PMC article.
Item in Clipboard
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy.
Francolini G, Frosini G, Di Cataldo V, Detti B, Carnevale MG, Banini M, Peruzzi A, Salvestrini V, Visani L, Olmetto E, Becherini C, Allegra A, Burchini L, Scotti V, Mangoni M, Meattini I, Desideri I, Livi L.
Francolini G, et al. Among authors: burchini l.
J Geriatr Oncol. 2023 Jan;14(1):101411. doi: 10.1016/j.jgo.2022.11.010. Epub 2022 Dec 8.
J Geriatr Oncol. 2023.
PMID: 36496347
Item in Clipboard
Cite
Cite